Login / Signup

Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.

Matthew H SecrestRobert W PlattColin R DormuthDan ChateauLaura TargownikRui NieCarla M DoyleSophie Dell'AnielloKristian B Filion
Published in: Pharmacoepidemiology and drug safety (2019)
Restriction to a single indication for treatment may reduce confounding by indication in studies conducted in distributed data networks and other large databases.
Keyphrases
  • big data
  • combination therapy
  • case control
  • artificial intelligence
  • neural network